Findings reveal altered osteoclast activity regulation in microgravity, suggesting new endocrine insights.
Exposure to microgravity during spaceflight induces excessive osteoclast activation, resulting in bone loss and dysregulation of calcium metabolism. Accumulating evidence from spaceflight and ground-based studies suggests that endocrine factors involved in osteoclast inhibition may be altered under microgravity conditions; however, the underlying regulatory mechanisms remain incompletely understood.
No takes yet. Share an insight, caveat, or question.
Hirayama et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: